Our technologies provide efficient enrichment of live rare cells from a standard tube of blood which can then be used for cellular and molecular analyses on genetics and physiological testing, and disease prediction.

• Study on Mechanism of Metastasis: isolation and culture of metastasis-initiating cells.
• Metastasis Models: development of metastatic cell line and mouse models.
• Drug Discovery: single cell sorting for discovery of metastasis targets.
• Mutation Analysis: cancer cell isolation and culture for cancer genomics DNA sequencing.
• Molecular diagnostics for therapy guiding: Global gene expression profiling of CTCs and immune cells can be developed for guiding therapy of individual patients.
• Companion diagnostics in cardiovascular disease: Blood test based on circulating endothelial cells (CECs) for high risk of cardiovascular disease.
• Genetic testing of fetal cells during pregnancy: Fetal cells in maternal uterus or blood, followed by FACS, for performing genetic testing of fetal cells in pregnant women.
• Development of drugs targeted to seprase and DPP4: Monoclonal antibodies against DPP4 and Peptide Inhibitors against seprase suppress tumor invasion, metastasis and angiogenesis.